Select day or Workshop to view agenda/faculty
Wednesday April 6th
Practice Management Workshop: Launching and Growing a Successful Age Management Practice
Many attendees of the AMMG conferences are attracted to the field of Age Management Medicine, but do not feel qualified, or empowered with the necessary tools, to successfully transition from the well-established structure of disease-based medicine or from the traditional insurance-based reimbursement system into a system which relies to a significant degree upon direct pay.
This workshop is designed to complement the AMMG Certification in Age Management Medicine for physicians and healthcare professionals and to help educate and inform medical and office staff. Attendees will be guided through the process of developing an Age Management Practice. Our goal is for the attendee to be equipped with the basic tools for making the necessary decisions on what is required from a Practice Management point of view.
Non-CME Course
FACULTY: Chuck Guglin, M.D., Francesca Guglin, Tony Orlando, Jeff Rubnioff and Joel Suraci
Time |
Presentation |
|---|---|
| 9:00 – 9:30 am | The Direct Pay/Partial Direct Pay Practice Model Chuck Guglin, M.D., FACS Owner, Hyperfit MD Age Management Center Understand what a direct pay practice is, learn what the best practices for this type of practice are and transcend the fear of moving from insurance-based to direct pay practice. Attendees will be asked to envision the ideal Age Management Practice they wish to develop. |
| 9:30 – 10:15 am | Development of Practice Services and Procedures Chuck Guglin, M.D., FACS Owner, Hyperfit MD Age Management Center Joel Suraci Clinical Specialist, Regenerative Medicine Technologies Samael A. Tejada President & Founder, LiquividaLounge.com Jeremy Edwards Director of Business Development, GAINSWave/FemiWave- USA It is critical to understand the scope of the Age Management practice and clearly define what services and procedures will be offered, and to develop a pricing structure. These can include Hormone Replacement, Nutrition, Weight Loss, Fitness, Regenerative Medicine, and Sexual Dysfunction, Aesthetic Procedures and others. |
| 10:15 – 10:30 am | Break |
| 10:30 – 11:15 am | Development of Diagnostic Tools and Procedures Chuck Guglin, M.D., FACS Owner, Hyperfit MD Age Management Center Tony Orlando President, DEXA Jeff Rubinoff Vice President, Ultrasound and C Arm Product Specialist, iRad Sales Group The development of diagnostic procedures is to a great extent a product of the practice services that will be offered to patients. What diagnostic procedures need to be offered to support the services to patients? What equipment will be required to implement the diagnostic procedures? This also includes development of relationships with pharmacies, laboratories and equipment providers. |
| 11:15 am – 12:00 pm | Motivating Patients and Creating Programs Applying the Science of Age Management Medicine to Produce Positive Patient Outcomes Rudy Inaba Vice President of Performance Health, Cenegenics Medical Institute, Las Vegas, NV Creating programs that will incorporate your defined services, creating a real change in the health of patients and retaining patients are critical to the success of your practice. |
| 12:00 – 1:00 pm | Lunch Break Lunch Provided |
| 1:00 – 2:00 pm | Developing a Marketing and Branding Program Audrey Neff Director of Marketing, Patient Now How to secure new patients and retain current patients through appropriate branding and marketing programs is essential to success. |
| 2:00 – 2:45 pm | Employee Management and Engagement Rudy Inaba Vice President of Performance Health, Cenegenics Medical Institute, Las Vegas, NV A culture of excellence starts with the right team and brand. How your patients perceive your practice is essential to developing trust, thus increasing referrals and patient retention. Learn how to engage your team in creatively promoting, not selling, your services to current patients and prospects. What employee skills will be essential? |
| 2:45 – 3:00 pm | Break |
| 3:00 – 3:45 pm | Client/Patient Experience Expectations Rudy Inaba Vice President of Performance Health, Cenegenics Medical Institute, Las Vegas, NV In the process of transitioning from sick-care to preventive healthcare you don’t want to sound like a salesman. Learn the exact words to use to speak to your patients and help them get the results they want to achieve. Learn how to set achievable patient goals and expectations. |
| 3:45 – 4:30 pm | Practice Landmines & Practice Pearls Chuck Guglin, M.D., FACS Owner, Hyperfit MD Age Management Center Learn what to avoid to eliminate or reduce the inevitable problems and those pearls from experienced Practice Management Professionals that can help you succeed. |
| 4:30 – 5:00 pm | EMR, Software and Forms Laura Barrera, MA Office Manager, Timeless Health, Miami, FL, Founder, Journey Health Coaching Platform Katelyn Meacham, BHSA Patient Concierge,Timeless Health, Miami, FL Recommendations on appropriate practice software and forms which may be required. |
| 5:00 – 5:15 pm | AMMG Physician and Healthcare Provider Certification Program Francesca Guglin CEO, Hyperfit MD Age Management Center |
| 5:15 – 5:30 pm | Open Forum with Q and A All Speakers |
Thursday, April 7th
Workshop: A Day of DNA Genetics & Epigenetics
Age Management Medicine rides the wave of medical innovation and clinicians must be updated and current on new evidence-based studies, topics, testing and treatment protocols involving genetics and epigenetics. This workshop is designed for that purpose. Current practicing clinicians will especially benefit from this new and cutting edge information.
Time |
Presentation |
|---|---|
| 7:00 – 7:45 am | Complimentary Breakfast Open to all attendees. Provided by the Age Management Medicine Group (AMMG) |
| 8:00 – 8:45 am | The Future of Genomic Health in Precision Medicine: Interpretation of Whole Genome Sequencing (WGS) Apostolos “Paul” Psychogios, M.D., FACMGG Director Clinical Genetics and Genomics Research, Comite Center for Precision Medicine & Health Whole Genome Sequencing (WGS) is a comprehensive method analyzing the entire genome being established as the most effective test for rare disease diagnosis. At the same time, it is a transformative diagnostic tool supporting the paradigm shift from disease-driven to prevention-oriented precision medicine. The American College of Medical Genetics and Genomics (ACMG) recommends WGS testing as an effective strategy in comparison with traditional single or multi-gene testing in patients with 1) a strong family history of a likely unknown genetic disorder or otherwise unspecified phenotype, 2) known but heterogeneous disorder, and 3) in affected individuals with previously nonconclusive genetic results. We have been offering WGS testing first in the practice since 2018 with an identification of a pathogenic (P) and likely pathogenic (LP) gene variant in approximately 71%. Our approach was specifically designed to offer 1) WGS at the first interaction with the client in conjunction with a comprehensive family history intake/pedigree analysis, medical record review, and examination, 2) continuous genome data reanalysis every 6 months especially for the initially non-diagnostic cases, and 3) continuous analysis of their phenome (phenomics). We believe that every individual, especially the most vulnerable ones, should have access to WGS-driven services first to precisely optimize their health and life outcomes. |
| 8:45 – 9:30 am | Update on Epigenetics: Understand the Power of Epigenetics from Biological Clocks, Immune Status, Telomere Lengths to Early Cancer Detection Edwin N. Lee, M.D. Assistant Professor of Internal Medicine, University of Central Florida College of Medicine The emerging science of epigenetics is exploding and exciting. Epigenetics is the science of how our environment and other factors can turn on or turn off our genes. “Epi” means on or above in Greek and one part of epigenetics is looking at the methylation on our DNA. There are over 26 million spots where methylation can occur on our DNA in each cell. Since 2013 we have epigenetic biological clocks that gives our biological age, which is far superior than chronological age for measuring the aging process; which is still the biggest risk factor for all chronic disease and death. There are several biological clocks that will be reviewed. Not all the commercially available biological clocks are the same. By using computer algorithms and artificial intelligence on the DNA methylation pattern we now have clinical application to do liquid biopsy to detect cancer including stage 0. Cancer screening, estimation of telomeres, immune status, and other clinical application of epigenetics will be reviewed. |
| 9:30 – 10:15 am | Turning Back Your Clock: Optimizing Epigenetics to Extend Your Healthspan for Life! Florence Comite, M.D. Founder, Comite Center for Precision Medicine, New York, NY Member, AMMG Planning Committee Diseases of aging arise as a result of systemic degradation to basic physiological function with chronological age, generally beginning in the 30’s. Importantly, these metabolic, hormonal, microbiome, genomic, and epigenetic alterations that were once undetectable at the cellular level have become quantifiable with the emergence of novel diagnostic tools throughout the early 21st century. Precision Medicine physicians and clinicians are poised to seamlessly integrate these tools into clinical and digital health practices to support their ultimate objectives of intricate personalization and health optimization for each person. A multifaceted approach is essential to optimize health and stop chronic diseases on a targeted N-of-1 basis. Our longitudinal research, derived from >20 years of scientific data, suggests that it is possible to detect, predict, and stop chronic disease. This lecture will illustrate how our patients can achieve healthy longevity through this evidence-based approach. |
| 10:15 – 10:30 am | Break |
| 10:30 – 11:15 am | Improving Outcomes in Cardiometabolic Disease with Genomics Sharon Hausman-Cohen, M.D., FAAFP, ABIHM Owner & Co-Founder, Resilient Health CMO, IntellxDNA This talk will show how genomics can be used to understand some of the root causes of cardiometabolic disease including inflammation and hormonal signaling and mitochondrial factors. It will then elucidate how this root cause approach can guide the development of a precision medicine plan for prevention and treatment that incorporates diet, lifestyle, supplementation and even targeted medications. |
| 11:15 am – 12:00 pm | Matching DNA with Interventions: Optimizing Weight and Nutrition for Your Body Type Elliot Dinetz, M.D. ABFM, FAAMFM Timeless Health, Miami, FL Member, AMMG Conference Planning Committee As we continue to see the role of Genomics in the way we practice medicine, we will explore Single Nucleotide Polymorphisms’ (SNP’s) role in tailoring medical care focusing on how to reverse obesity and diet related health conditions based on the individual’s genetic predisposition and needs. In reviewing well-studied SNPs we will dive into how to utilize this tool as part of a systems biology approach for advanced prevention and reversal of disease processes, a far leap from the way conventional medicine is managing them. This allows physicians to customize ideal lifestyle as well, from optimal exercise to unveiling food aversions and inflammation. Alleviating the need for trial and error ultimately limits patient suffering and is the new frontier in healthy aging. Excellent for experienced Integrative health providers or new to genetics primary care physicians, this dive into the literature will allow the practitioner to start making clinical improvements to their practice come Monday morning. |
| 12:00 – 1:30 pm | Lunch Break |
| 1:30 – 2:15 pm | Epigenetics: Theory, Testing, and Using it to Guide Clinical Recommendations Daniel Stickler, M.D. Co-Founder/Chief Medical Officer, Apeiron Epigenetics is quickly becoming an important tool in patient assessment and many physicians are lacking adequate training required to utilize and interpret the results to guide clinical decisions.Topic areas:
Understanding these new techniques will provide clinicians with a new and beneficial tool to guide clinical assessment and planning. |
| 2:15 – 3:00 pm | A Root Cause Analysis of “Essential Tremor” Through the Lens of Functional Genomics David C. Socol, M.D. Family Practice Physician, Beverly Hills, CA The conventional approach to treating essential tremor migrates from observation to the prescription of beta-blockers and perhaps onward to stereotactic surgery. In this root cause analysis using functional genomics as a preferred clinical decision-making tool, the etiology of essential tremor becomes a symptom of genomic polymorphisms that intersect with epigenetic influences. This genomic insight provides the clinician with a unique opportunity to disrupt the pathophysiology of essential tremor and improve long-term outcome using therapeutic interventions that are tailored to the unique genomic polymorphisms of an individual. |
| 3:00 pm | Exhibits Open |
| 3:00 – 3:45 pm | Break / Visit Exhibits |
| 3:45 – 4:30 pm | Nutritional Deficiencies and Genetics: Optimizing Precision Health Outcomes with N-of-1 Ashley Madsen, PA-C Comite Center for Precision Medicine, New York, NY Nutrigenetics is a nascent and exciting field of study, focusing on the relationship between genetic variation and nutrient absorption, utilization, and daily requirements in the individual. With Precision Medicine, clinicians can utilize this N-of-1 data to further optimize each patient’s metabolism and nutrient balance through medications, supplements, and dietary recommendations. This presentation introduces the core principles of nutrigenetics before exploring notable gene-nutrient relationships in the literature. After laying the groundwork, we illustrate the many ways we have integrated nutrigenetics into our clinical practice and consider advanced applications for the future. Audience members will learn the importance of nutrigenetics as a diagnostic tool in Precision Medicine to improve health outcomes via nutrient status. |
| 4:30 – 5:30 pm | Your Genes Are Not Your Destiny: Re-engineering your physiology with N-of-1 interventions Lauren Klein, PA-C Comite Center for Precision Medicine, New York, NY Precision Medicine is grounded in the collection, integration, and interpretation of N-of-1 data to assess disease risk and improve health outcomes in every patient. Family history is an essential piece to this assessment, which illustrates what may present in a patient’s health trajectory with time and age. As biotechnology has advanced in the 21st century, genetic testing has become less expensive and more accessible for clinicians practicing age management medicine. Together with family history, clinical insights derived from genetic testing can revolutionize the quality and efficacy of preventive care. This presentation covers the core principles of Precision Medicine, followed by an extensive review on the utility of genetic testing in our clinical practice. Audience members will learn how to interpret genetic data to optimize cardiovascular health and slow the aging process. |
| 5:30 – 7:00 pm | AMMG Welcome Reception Open to all conference attendees, spouses, and guests Held in Conference Networking and Exhibits Center |
Thursday, April 7th
Workshop: Introduction to Core Issues in Age Management Medicine
Course is designed to familiarize physicians and healthcare professionals with the basics of Age Management Medicine. Covers evidence-based use of nutrition, supplements, fitness, hormones—including a specialized lecture on hGH and assessment protocols—and legal basics, with some of the newest medical science on aging that may be in use now or in the near future; including relevant case presentations and discussion.
Time |
Presentation |
|---|---|
| 8:00 – 9:00 am | Basic Hormone Replacement/Replenishment for Men Neal Rouzier, M.D. Director, The Preventive Medicine Clinics of the Desert, Palm Springs, CA Aside from routinely prescribing testosterone for men, it is important to understand many basic concepts before doing so. Wading through disagreements and issues with peers can also become problematic if you are not well-versed in the literature and controversies. Prescribing hormones for men can be simple, however, dealing with side effects and complications is not. This lecture will address common problems, complications, side effects, monitoring, understanding levels, erythrocytosis vs. polycythemia, prostate cancer and elevated PSA, use of 5 alpha reductase inhibitors, and aromatase inhibitors and the harm of blocking DHT and estrogen. Prescribing testosterone to men is easy in 90% of the time. However, it is the other 10% that requires skill, experience, insight, and command of the medical literature to appropriately treat routine and confusing cases. This lecture will review many usual as well as unusual cases and scenarios that will enable the experienced clinician to handle those difficult cases. A literature review will be provided to support why we do what we do in various scenarios. |
| 9:00 – 10:00 am | Hormone Supplementation for Women: Essentials for Competent, Effective Prescribing Angela DeRosa, D.O., MBA, CPE Founder & President, Hormonal Health Institute, Scottsdale, AZ Melissa Loseke-Ablett, D.O. Chief Medical Officer, Limitless Male Medical, Omaha, NE Medical Director, Trillion, Omaha, NE This lecture will provide an overview of proper assessment of women before hormone prescribing, available options for bioidentical estradiol, progesterone, and testosterone, dosage ranges, and appropriate follow-up. Emphasis will be placed on research along with significant clinical experience of the speaker. |
| 10:00 – 10:15 am | Break |
| 10:15 – 11:15 am | Clinical Use of Supplements in an Age Management Medicine Practice Derrick DeSilva, Jr., M.D. Teaching Faculty, JFK Medical Center, Edison, NJ Associate Attending Staff, Raritan Bay Medical Center, Perth Amboy, NJ As practitioners in functional medicine and “age management,” our patients expect that we have and utilize the best options to guide them to optimize their health and protect them from the common problems associated with aging such as heart failure, stroke, osteoporosis, and cognitive impairment. Contrary to the standard RDA for nutrients, various factors that contribute to a person’s actual needs include: decreased ability to absorb nutrients, medications that many deplete the body of certain nutrients, and environmental factors that contribute to a greater need. This presentation will provide an overview of the mechanism of action of nutraceuticals and supplements in the protection from the untoward effects of inflammation, oxidative damage, endothelial dysfunction and how they can be applied in your practice for the prevention and treatment of common medical conditions seen in the aging population. |
| 11:15 am – 12:00 pm | Improving Growth Hormone With and Without Growth Hormone Edwin N. Lee, M.D., FACE Assistant Professor of Internal Medicine, University of Central Florida, College of Medicine, Orlando, FL Founder, Institute for Hormonal Balance, Orlando, FL Member, AMMG Conference Planning Committee Growth hormone is an essential hormone in lowering body fat, improving on lipids, keeping muscles healthy and improving on bone density. Adult growth hormone deficiency symptoms will be reviewed and the association of higher mortality with growth hormone deficiency. Unfortunately the treatment with recombinant human growth hormone is not covered under most insurance plans and it is also cost prohibitive for most people. There is an alternative to the expensive recombinant human growth hormone most commonly used for boosting IGF-1 and has the advantage of inducing all five of the hGH isoforms rather just the one that is found in the synthetic form. Several peptides have been shown to improve IGF-1 levels and they will be reviewed. Unfortunately, the FDA has banned several of the Growth hormone releasing peptides. In addition the diagnosis of adult onset growth hormone deficiency and the use of human Growth Hormone will be reviewed. |
| 12:00 – 1:30 pm | Lunch Break |
| 1:30 – 2:15 pm | Use of Fitness & Exercise in an Age Management Medicine Practice Mary Corry, MSN, ED Medical Education Specialist, Worldlink Medical, Salt Lake City, UT Member, AMMG Conference Planning Committee Member, Sigma Theta Tau International Honor Society of Nursing One of the key components to Age Management Medicine is exercise. During this presentation, we will discuss the benefits of exercise and how to build an effective exercise program for beginner and advanced patients. |
| 2:15 – 3:00 pm | Compliance with Federal and State Regulations as You Begin Your Age Management Practice John Leardi, Esq. Member, Buttaci, Leardi & Werner Law Firm, Princeton, NJ Recognize when relevant Federal and State regulations are implicated within your age management practice and measure and evaluate necessary steps to ensure compliance with these statutes and regulations. This workshop will focus on one essential element; compliance as an ongoing process. Compliance with Federal and State regulations depend entirely upon a provider’s willingness to be motivated, alert, and self-critical. Compliance and compliance plans are a risk management tool that should address each and every area of potential exposure. Good faith efforts to focus on and implement thorough compliance mechanisms evidences a provider’s commitment to compliant and ethical practice and therefore undermines any allegation of intentional malfeasance. Compliance with Federal and State regulations is not only important when beginning a new practice, but is an essential element to the ongoing success of that practice. Continual monitoring of compliance “hot spots,” which requires a comprehensive understanding of the relevant regulatory framework, helps identify issues before they escalate into problems that could result in liability. |
| 2:30 pm | Exhibits Open |
| 3:00 – 3:40 pm | Break / Visit Exhibits |
| 3:40 – 4:30 pm | Age Management Medicine Clinical Recommendations for Diet and Weight Loss Rob Kominiarek, D.O., FACOFP Member, AMMG Planning Committee Director, ReNue Health, Springboro, OH Assistant Clinical Professor, Ohio University College of Osteopathic Medicine Obesity has gained epidemic proportions and is now the leading cause of chronic medical illnesses that occur as we age. Correcting obesity should therefore be paramount for every physician who practices age management medicine. Old concepts of weight-loss, such as low-fat diets, have been shown to actually increase cardiovascular risks. The Mediterranean diet has been proven to have beneficial effects on health but, per se, may not provide a good option for losing weight. Newer concepts such as higher fat diets, ketogenic diets and fasting mimicking diets have accumulated a plethora of evidence that suggests these appear to be preferred options for patients to lose weight. Physicians should consider this new evidence when recommending weight-loss options. |
| 4:30 – 5:30 pm | Assessing the Age Management Patient Michale “Mickey” Barber, M.D. CEO & CMO, Better Life Carolinas, Charleston, SC & Charlotte, NC This lecture will focus on the many aspects of a patient’s health and fitness that should be evaluated as part of the initial assessment. This assessment should provide the patient and clinician with information about the patient’s health and disease history, nutritional patterns, sensitivities and supplement history. An assessment of fitness, strength and balance are also considered to be essential to setting up goals for a healthy aging program. The measurement and interpretation of key aging biomarkers including hormones will be discussed. The impact of stress on our health and longevity is well known and should also be assessed from day one of beginning an age management program. Attendees should leave this lecture with a good understanding of a basic as well as advanced age management assessment protocol. |
| 5:30 – 7:00 pm | AMMG Welcome Reception Open to all conference attendees, spouses, and guests Held in Conference Networking and Exhibits Center |
Thursday, April 7th
Workshop: Traumatic Brain Injury: A Clinical Approach to Diagnosis and Treatment
This full day program, TBI–A Clinical Approach to Diagnosis and Treatment, will provide to the attendees overwhelming information culled from peer-reviewed articles on Traumatic and Non-Traumatic Brain Injuries as causative factors for personality changes, cognitive impairment and mood disorders leading up to suicide. The attendees will be walked through the literature discussing the effects of primary traumas and the secondary effects of inflammation and oxidative stress on functionality. The rising cases of post-Covid neurological complications will also be discussed as a new entry into non-traumatic brain injury due to the “Cytokine Storm”. This program will prepare you for the treatment.
Course Faculty (all sessions in this track)
Mark L. Gordon, M.D.
Medical Director, Millennium-TBI & The Millennium Health Centers, Encino, CA; CBS Studios;
USC, Keck School of Medicine, Department of Family Medicine, Los Angeles, CA
Medical Director of Education, Access Medical Laboratories, Jupiter, FL
Member, AMMG Conference Planning Committee
Life Member, AMMG
Time |
Presentation |
|---|---|
| 8:00 – 9:00 am | An Introduction to Traumatic Brain Injury A 60-minute overview of trauma and non-traumatic brain injuries and the social and medical impact and the need for a paradigm shift in evaluation and treatment. |
| 9:00 – 10:15 am | The Laboratory of Traumatic Brain Injury The assessment of neurotrauma using trophic, neurosteroids, and neuroactive steroids as markers for hormonal deficiencies that are caused by both the primary and secondary injuries associated with neurotrauma (TBI). The literature supported view that the “standard reference” ranges and “normal” reference ranges are not relative to the patient. Interpretation of the lab results using the Median Theory of optimal levels. |
| 10:15 – 10:30 am | Break |
| 10:30 – 11:30 am | Traumatic Brain Injury and Neurobehavior The impact of neurosteroid deficiencies on both personality and mental abilities is clearly discussed in peer-reviewed articles. Those same articles provide support for mood and anxiety disorders developing from loss of the regulatory effects of many of the neurosteroids that are produced in the brain. |
| 11:30 am – 12:00 pm | Neuroinflammation and Oxidative Stress, the Foundation for Treating Traumatic Brain Injury, Part I The major impact of trauma is the production of secondary injury precipitated by free radicals and oxidative stress. The use of specific anti-oxidants and the regeneration of the glutathione system in the brain can help to regain a neuro-permissive environment that can allow for cellular repair and regeneration. |
| 12:00 – 1:30 pm | Lunch Break |
| 1:30 – 2:30 pm | Neuroinflammation and Oxidative Stress, the Foundation for Treating Traumatic Brain Injury, Part II Continuation of the 5th lecture with specific application and treatment of traumatic brain injury. A number of cases will be discussed. |
| 2:30 – 3:30 pm | Putting it All Together with Case Studies 10 comprehensive cases will be dissected and presented with attendees’ participation as a means of consolidating the information that will be shared throughout the day. |
| 2:30 pm | Exhibits Open |
| 3:30 – 4:10 pm | Break / Visit Exhibits |
| 4:10 – 5:30 pm | Case Studies and Q&A Continuation of the cases with attendee participation and Q&A. The goal of these cases is to allow the audience an opportunity to work out with the lecturer the initial evaluation of the patient, laboratory testing, interpretation of the test results, and selection of an optimal treatment protocol. |
| 5:30 – 7:00 pm | AMMG Welcome Reception Open to all conference attendees, spouses, and guests Held in Conference Networking and Exhibits Center |
Thursday, April 7th
Workshop: Office Based Aesthetics for the Age Management Medicine Clinician
In response to attendee requests for information on aesthetic protocols and treatments which are office based and can be done by non-board-certified Age Management Clinicians either full time or as an adjunct to their existing practice, the decision not to accredit this track was made so that attendees could be provided with business tools as well as the science and medical information necessary to implement these procedures. The goal is not to make this track commercial but to give speakers in this niche area the leverage to openly discuss procedures and answer questions that could be severely restricted in an accredited environment. This track is also very appropriate for Support Staff.
* Track is Non-CME
Time |
Presentation |
|---|---|
| 8:00 – 8:30 am | Adding Office Based Aesthetics to Your Existing Practice to Increase Revenue and Patient Retention H. William Song, M.D. Founder & CEO, Omni Aesthetics, Oakland, NJ Learn a simple start-up business model; low investment with high return; what are your patients looking for; what procedures are viable that are office based and do not require a board certification; and what is new in the field of Age Management Medicine. |
| 8:30 – 9:00 am | Developing a Dynamic and Comprehensive Office Based Aesthetic Procedure Selection Marie Piantino, L.E. President, AAEG You have made the decision to add Aesthetics to your practice. Learn how to combine your procedures to add excitement to your menu and utilize all equipment. Increase your revenue by “ Add On’s”— what to use and how much. Retail business: Why have it? What’s its cost, and how to sell! |
| 9:00 – 10:00 am | Latest Update on Stem Cells and Exosomes for Aesthetics H. William Song, M.D. Founder & CEO, Omni Aesthetics, Oakland, NJ When and how to use! What do I look for to evaluate quality/efficacy? Get the latest update on what’s approved and how to use it. Are there alternatives? |
| 10:00 – 10:15 am | Break |
| 10:15 – 11:15 am | Hair Restoration (Includes Demonstration) Naomi Fayzulayev, NP Functional Nurse Practitioner, NHL Med Aesthetics, Scottsdale, AZ Why is the procedure so popular? Do I add this now and how? What’s the cost versus profit and does it work? Where do I get trained, how long is a course, and rough costs. Topics will include Introduction into Alopecia, Prevention Programs for Hair Loss, How to maximize the efficacy of injectables for the scalp, PRP, Exosomes, Microneedling + Growth Factors, How to increase workflow in the treatment room. |
| 11:15 am – 12:00 pm | Micro Needling (Includes Demonstration) Marie Piantino, L.E. President, AAEG Find out about reclassification, why it’s now a Class 2. What to look for in a device, how to incorporate into a business model, menu selection, training, and marketing. What’s the cost to implement and what is profitability? |
| 12:00 – 1:30 pm | Lunch Break |
| 1:30 – 2:15 pm | Treating Ethnically Diverse Skin & Aesthetic Issues Tammy Polit, M.D. Medical Director, Beautopia Cosmetic Medicine, Colleyville, TX Proper skin assessments and aesthetic treatment delineations are necessary to meet the growing demand for aesthetic treatments in all ages that include various pigmentation levels and skin health needs. We will review client requests vs clinical recommendations in light of the Fitzpatrick pigmentation scale and evaluation of levels of skin health and skin aging. Treatment options will vary based on this combination of assessments. |
| 2:15 – 2:45 pm | Should Skincare/LED/ Aesthetic Devices be Offered for Home Use? Jordan R. Plews, Ph.D. CEO & CSO, Elevai Labs Consultant, Epigenetic Gene Editing (EGE) and TackleBio What’s the latest in skincare? Find out about ingredients, delivery systems and anti-aging programs. Retailing equipment for at-home use by patient, is this safe? What’s the latest in LED for wrinkles/hair/pigment/rosacea. |
| 2:45 – 3:30 pm | Demonstrations of Office Based Cosmetic Peels, Products for Ethnically Diverse Skin and LED Aesthetic Devices (Includes Demonstration) Tammy Polit M.D. Medical Director, Beautopia Cosmetic Medicine, Colleyville, TX Identifying our patients needs and supplying a treatment programs that are suitable. Precautions and pre treat/post care programs. Why use LED? Which are the best peels and why? |
| 2:30 pm | Exhibits Open |
| 3:30 – 4:00 pm | Break / Visit Exhibits |
| 4:00 – 4:45 pm | PRP or PRF: What is the Difference? Which Do I Use? H. William Song, M.D. Founder & CEO, Omni Aesthetics, Oakland, NJ Find out what qualifies for PRP, platelet count/how to constitute/what kind of centrifuge. What’s the difference in PRP to PRF and when to use which. Do I need a separate system or special kit? |
| 4:45 – 5:30 pm | The Good, The Bad, and the Dirty in Skincare: What the Skincare Industry Does Not Tell You About Dirty Ingredients Derrick DeSilva, Jr., M.D. Teaching Faculty, JFK Medical Center, Edison, NJ Associate Attending Staff, Raritan Bay Medical Center, Perth Amboy, NJ Our skin is the largest organ system in the body and receives approximately 1/3 of the circulating blood in the body. American women use an average of 12 personal care products that contain 168 different chemicals and American men use an average of 6 personal care products that contain 85 different chemicals. Many of the ingredients that are applied to the skin have the potential to disrupt the endocrine system and become triggers for various epigenetic (environmental triggers) changes that can disrupt numerous systems in the body. Fortunately, there are a variety of nutrients and supplements that can block and negate the potential dangers of some of these toxic ingredients. During this presentation we will examine the questions that need to be asked about the various products/ingredients and look deeper into the safety of the ingredients that are used to produce these products. We will also evaluate what basic nutrients can be used to clean these toxins out of the body and improve the efficacy of skin care. The question is, are you willing to settle for the skincare you are currently using? We will discuss healing the skin from INSIDE-OUT. |
| 5:30 – 7:00 pm | AMMG Welcome Reception Open to all conference attendees, spouses, and guests Held in Conference Networking and Exhibits Center |
Friday, April 8th
General Session Curriculum
Time |
Presentation |
|---|---|
| 7:00 – 8:00 am | Treating Growth Hormone Deficiency Presented by Mark Gordon, MD Open to all attendees and includes a complimentary lunch Non-CME symposium sponsored by University Compounding Pharmacy |
| 8:00 – 8:05 am | Opening Remarks |
| 8:05 – 8:20 am | Update on the State of Affairs for HRT and Compounding: Impact on Clinicians Michale “Mickey” Barber, M.D. CEO & CMO, Better Life Carolinas, Charleston, SC & Charlotte, NC |
| 8:20 – 9:10 am | Rendering Alzheimer’s Treatable: Functional Medicine Approach to the Treatment of Alzheimer’s Disease Dale E. Bredesen, M.D. Professor, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, UCLA Founding President and CEO, Buck Institute for Research on Aging Author, The End of Alzheimer’s (NYTimes Bestseller) The COVID-19 pandemic has taken the lives of approximately one million Americans, but for perspective, Alzheimer’s disease will lead to the death of nearly 50 times that many of the currently living Americans if effective treatment and prevention are not introduced. Using a personalized, network-medicine approach, we recently reported successful results from a proof-of-concept trial. These results, coupled with successful results from prevention trials such as the FINGER study, suggest that large-scale efforts to reduce the global burden of dementia are now in order, and that such efforts could indeed make Alzheimer’s disease optional. |
| 9:10 – 10:00 am | The Genomics of a Pandemic: Human Polymorphisms, Viral Sabotage and Functional Medicine Solutions David C. Socol, M.D. Family Practice Physician, Beverly Hills, CA Why is it that individuals with the same co-morbidities can have vastly disparate responses to infection with the same SARS-CoV-2 variant? What distinguishes wild-type coronavirus from SARS-CoV-2? And what functional medicine alternatives can healthcare providers use to successfully reduce the risk of infection and mitigate the depth and severity of SARS-CoV-2 infection in vaccinated and unvaccinated individuals through the lens of genomics? This AMMG presentation acknowledges the influence of body composition, metabolic disease, the hormonal milieu and micronutrient status on the immune system and viral infection, and moves beyond it to explore genomic polymorphisms that contribute to viral susceptibility and host inflammatory response. Genomic features of SARS-CoV-2 that exploit host susceptibilities will also be explored in tandem with dynamic, evidence-based alternatives to the prevention and treatment of viral infections and SARS-CoV-2 in particular. |
| 10:00 – 10:30 am | Break / Visit Exhibits |
| 10:30 am – 11:15 am | Precision Medicine + Health: Is it Time to Explore the Genome to Optimize Health for Life? Florence Comite, M.D. Founder, Comite Center for Precision Medicine, New York, NY Diseases of aging arise as a result of systemic degradation to basic physiological function with chronological age, generally beginning in the 30’s. Importantly, these metabolic, hormonal, microbiome, genomic, and epigenetic alterations that were once undetectable at the cellular level have become quantifiable with the emergence of novel diagnostic tools throughout the early 21st century. Precision Medicine physicians and clinicians are poised to seamlessly integrate these tools into clinical and digital health practices to support their ultimate objectives of intricate personalization and health optimization for each person. A multifaceted approach is essential to optimize health and stop chronic diseases on a targeted N-of-1 basis. Our longitudinal research, derived from >20 years of scientific data, suggests that it is possible to detect, predict, and stop chronic disease. This lecture will illustrate how our patients can achieve healthy longevity through this evidence-based approach. |
| 11:15 am – 12:00 pm | New Markers for Aging George Shapiro, M.D. Chief Medical Innovation Officer, Fountain Life Adjunct Assistant Professor Clinical Medicine, New York Medical College, Valhalla, NY Founding Partner, Cenegenics, New York City Member, AMMG Conference Planning Committee Over 25,000 biomarkers have been identified, I will review the newest biomarkers related to aging, stressing those that are related to improving human health, preventing age-associated diseases, and extend a healthy life span. Combined with artificial intelligence and machine learning techniques, biomarkers of aging will have tremendous potential to improve human health in aging societies. Blood based, physiological, neurological and AI driven age prediction biomarkers will be discussed. Clinical trials using various therapies such as Rapamycin, GH, DHEA, Metformin, Allogeneic Stem Cells, Autologous Exosomes and new lipid therapeutics while monitoring human subjects with up to 5 aging biomarkers will be reviewed. |
| 12:00 – 1:00 pm | MythBusters: Myth Doctors Believe Regarding Taxes, Lawsuits, and Estate Planning that Put Your Life and Practice at Risk Presented by Art McOmber, Former FBI Special Agent Open to all attendees and includes a complimentary lunch Non-CME symposium sponsored by Fortune Law Firm |
| 12:00 – 1:30 pm | Lunch Break / Visit Exhibits |
| 1:30 – 1:45 pm | Why Undergo Certification in Age Management Medicine Derrick DeSilva, Jr., M.D. Teaching Faculty, JFK Medical Center, Edison, NJ Associate Attending Staff, Raritan Bay Medical Center, Perth Amboy, NJ |
| 1:45 – 2:30pm | Controversies of Growth Hormone: Does GH Cause Cancer and Does GH Reverse Aging? Edwin N. Lee, M.D., FACE Assistant Professor of Internal Medicine, University of Central Florida, College of Medicine, Orlando, FL Founder, Institute for Hormonal Balance, Orlando, FL Member, AMMG Conference Planning Committee There are two recent controversies on the use of growth hormone. The first controversy is the link of cancer and growth hormone. The history of growth hormone will be reviewed. In addition, subsets of population (children and adults on GH, Laron syndrome (Low IGF-1) and acromegalics (high IGF-1) will be analyzed for the risk of cancer. The second controversy of growth hormone is, is it good or detrimental to aging? On one side of the argument is increasing IGF-1 levels is considered the fountain of youth. The other side of the argument is that growth hormone (in acromegaly) can accelerate the aging process. Data will be reviewed on both sides of this area of controversy, including the new study of growth hormone reversing aging. |
| 2:30 – 3:15 pm | The Evidence Based Case for Blocking Estrogen Conversion in Men: A Literature Review of the Harm of High Estrogen Levels in Men and the Suggested Use of Aromatase Inhibitors in Men Neal Rouzier, M.D. Director, The Preventive Medicine Clinics of the Desert, Palm Springs, CA It has become customary to use aromatase inhibitors to block formation of estrogen in men. Even though the use of AI’s is commonly taught, the utilization is not necessarily supported by the medical literature. However, I will make the case for the use of AIs in men based on multiple studies suggesting that high levels of estrogen in men are associated with CVD harm and symptoms. This can have significant adverse consequences on men’s health. The purpose of this lecture is to present the literature demonstrating the need to block estrogen in men with aromatase inhibitors. Using the medical literature, we will come to understand the importance of keeping estrogen levels low in men The medical literature will be cited as it pertains to the harm of elevated levels of estrogen in men. |
| 3:15 – 4:00 pm | Break / Visit Exhibits |
| 4:00 – 4:45 pm | The Evidence Based Case Against Blocking Estrogen in Men John C. Carrozzella, M.D., MSMS Director & Founding Physician, CEO, Florida Center for Hormones and Wellness Since testosterone went “underground” in the 1970’s, shortly after it became a controlled substance following the “performance enhancing drug” legislation by Congress, many have come to believe that it was important to block its conversion into the “female” hormone, Estradiol. This concept was further enhanced by observational literature that showed an “association” with elevated Estradiol and many disease conditions in men. It has since become an “accepted dictum” that Estradiol should be blocked during the course of Testosterone therapy in men. However, higher quality prospective studies published more recently, show that when Estradiol is blocked (such as in the treatment of prostate and other cancers), severe medical consequences follow and when Estradiol is allowed to rise without blocking, less disease and debility ensue. This discussion will review significant recent literature showing that allowing Estradiol levels to rise with Testosterone treatment is not only safe but medically essential. |
| 4:45 – 5:30 pm | Panel Discussion: An Interactive Conversation with Experienced Age Management Physicians: Issues and Controversies in Treatments, Estrogen Use in Men Moderator: Rob Kominiarek, M.D. Panel: John C. Carrozzella, M.D., MSMS & Neal Rouzier, M.D. Details to come. |
Saturday, April 9th
General Session Curriculum
Time |
Presentation |
|---|---|
| 8:00 – 9:00 am | The Dangers of Inhibiting Estrogen in Men Rob Kominiarek, D.O., FACOFP Member, AMMG Planning Committee Director, ReNue Health, Springboro, OH Assistant Clinical Professor, Ohio University College of Osteopathic Medicine Estradiol is a pleiotropic hormone that has instrumental influence over numerous critical functions related to the cardiac and vascular system, bone and mineral metabolism, cognition, memory, mood, balance, age related neurodegenerative disorders and lipolysis of fat. Evidence suggests that estradiol has neurotrophic and neuroprotective properties and promotes the survival and viability of intimate brain structures. The benefits of estradiol on neuroprotection are attributed to genomic and non-genomic signaling, regulation of mitochondrial energy and antioxidant action. Damaged neurons increase the production of aromatase, the enzyme that is responsible for the conversion of androgens into estradiol. Our own astrocytes after suffering trauma increase aromatase expression to exert the numerous benefits of estrogen to these intimate structures. Knowing all this to be an evident truth, why then do some clinicians insist on blocking the aromatization of testosterone into the ever-important, pleiotropic hormone estradiol? Attendees will learn the importance of allowing the natural aromatization of testosterone into estradiol to occur and how blocking this important conversion will do long term harm to these numerous systems. |
| 9:00 – 10:00 am | The Fallacy of Testosterone Precipitated Erythrocytosis Neal Rouzier, M.D. Director, The Preventive Medicine Clinics of the Desert, Palm Springs, CA There are long term studies and literature support for testosterone improving longevity and decreasing the diseases of aging. However, testosterone has also been implicated in significant side effects, the most common of which is termed polycythemia. Therefore, it has become customary to phlebotomize men on testosterone therapy that experience an elevated hemoglobin/hematocrit, which is the most common side effect of testosterone therapy. The Endocrine Guidelines require regular monitoring of therapy for this elevated hematocrit, commonly referred to as polycythemia. However, despite what most believe, testosterone does not cause polycythemia vera (PCV) nor does it cause an increase in arterial or venous thrombosis as commonly seen with PCV. Nevertheless, the erythrocytosis that is prevalent with testosterone administration is commonly extrapolated to be just as harmful as polycythemia vera, which is a blood disorder that increases the risk of blood clots, both arterial and venous. This is both an incorrect and inappropriate extrapolation due to misunderstanding of the terms. Although the widespread use of phlebotomy as the treatment of erythrocytosis is common, erythrocytosis is not polycythemia vera nor should the harm of PCV be extrapolated to be the same for physiologic erythrocytosis. The literature supports no harm of physiologic erythrocytosis caused by either testosterone or living at altitude, and this elevation of red blood cells does not require treatment even though it has been the typical standard operating procedure for decades. Erythrocytosis does not result in the same harm as true PCV and assuming that it does is both incorrect and leads to inappropriate treatment. We should not extrapolate or misconstrue the two entities, although most hematologists and cardiologists will disagree. The purpose of this lecture is to present the literature support of lack of harm of testosterone-induced erythrocytosis or the need to phlebotomize men with erythrocytosis, even though multiple medical society guidelines recommend regular monitoring and phlebotomy. The safety of erythrocytosis and the difference between erythrocytosis and thrombo-producing PCV will be reviewed. The importance of following evidence-based standards, and not public opinion, will be explained and demonstrated. Reality is not consensus of opinion, yet this seems to be the case when it comes to testosterone-induced erythrocytosis or altitude-induced erythrocytosis. However, it has become customary to phlebotomize men with an elevated hemoglobin/hematocrit, the most common side effect of testosterone therapy. The most recent hematologic literature does not recommend treatment or phlebotomy for that which is termed secondary polycythemia (physiologic erythrocytosis) induced by testosterone therapy, living at altitude, or that produced by emphysema (COPD). Secondary polycythemia (erythrocytosis) is not PCV, nor does it cause the thrombotic complications of PCV, nor does it require the standard treatment of PCV. The literature supports no harm of secondary polycythemia caused by testosterone administration, from living at altitude, COPD, or congenital heart disease with right to left shunt. Medical society guidelines continue to suggest otherwise despite evidence to the contrary. The most recent literature will be reviewed demonstrating the most current recommendations contrary to what we have been misled to believe. |
| 10:00 – 10:30 am | Break / Visit Exhibits |
| 10:30 – 11:15 am | Medical Use of Psychedelics: Addiction, Depression, Anxiety, Obesity, Heart Disease, Diabetes and PTSD Derrick M. DeSilva, Jr., M.D. Teaching Faculty, JFK Medical Center, Edison, NJ Associate Attending Staff, Raritan Bay Medical Center, Perth Amboy, NJ The psychedelic effects of some plants and fungi have been known and deliberately exploited by humans for thousands of years. Fungi, particularly mushrooms, are the principal source of naturally occurring psychedelics. Psychedelic use was largely associated with the “hippie” counterculture movement, which, in turn, resulted in a growing, and still lingering, negative stigmatization for psychedelics. As a result, in 1970, the U.S. government rescheduled psychedelics as Schedule 1 drugs, ultimately ending scientific research on psychedelics. Since then, significant advances have been made in characterizing the chemical properties of some of these psychedelic compounds as well as their therapeutic uses. This presentation will explore the potential of the role for psychedelics in the treatment of a variety of neuropsychiatry-related conditions (depression, anxiety, addiction, PTSD, OCD etc.) especially during this time of COVID, and examine recent advances as well as current research in this newly emerging field of therapeutics. |
| 11:15 am – 12:00 pm | ALS and Dr. Roy Walford Kenneth S. Sharlin, M.D., MPH Diplomate, American Board of Psychiatry and Neurology Director, The Brain Tune Up! Program, #1 Bestselling Author of The Healthy Brain Toolbox Sharlin Health and Neurology/Functional Medicine Dr. Roy Walford was the preeminent aging researcher and thought leader of his time. He published more than 340 scientific papers, authored 7 books, served on numerous committees, and won many prestigious awards. He was also one of seven terranauts who participated in the experimental Biosphere 2 project in the Arizona desert between 1991 and 1993. Despite his accolades, and his self-experimentation with strategies to prolong the aging process, Walford died of Amyotrophic Lateral Sclerosis at the age of 79. This presentation examines the life of Roy Walford to frame an understanding of ALS and offer a unifying theory of its pathogenesis, along with a structure for a clinical approach ideal for integrative practitioners whose focus is chronic neurodegenerative disease. |
| 12:00 – 1:30 pm | Lunch Break / Visit Exhibits |
| 12:00 – 1:00 pm | Working within IRS Guidelines to Develop Tax Strategies to Maximize Income Presented by Damon Parker, Former F-18 Fighter Pilot Open to all attendees and includes a complimentary lunch Non-CME symposium sponsored by Top Doc |
| 1:30 – 2:15 pm | Food as Medicine John E. Lewis, Ph.D. Voluntary Associate Professor, Departments of Psychiatry and Behavioral Sciences and Psychology, University of Miami This lecture will feature some of the latest nutrition science information, starting with some of the basic facts and principles around nutrition and dietary behaviors, the links between inadequate nutrition and chronic diseases, the benefits of dietary supplementation, the importance of bioavailability of active ingredients, and why certain polysaccharides are crucial for health. Dr. Lewis will discuss the results of his extensive line of research on how polysaccharides modulate the immune system and other organ systems in the context of patients with Alzheimer’s, HIV, MS, non-alcoholic fatty liver disease, and healthy adults. Having a proper understanding of the evidence base of nutrition and dietary supplementation and their relationships to chronic disease is important for all allied health practitioners and wellness industry professionals, especially considering all of the marketing hype around diet, food, and dietary supplements. Dr. Lewis’s lecture provides attendees an evidence-based review of nutrition science that emphasizes some recent important findings that have an impact on health and quality of life. |
| 2:15 – 3:00 pm | Orthobiologics for Age-Related Musculoskeletal Conditions: Ushering Sports Medicine into the 21st Century Dallas Kingsbury, M.D., FAAPMR, CAQSM, RMSK Medical Director, Fountain Life, Naples, FL Assistant Professor of Physiatry, Rusk Rehabilitation at NYU Langone, Teaching Faculty Orthobiologics: Bringing Sports Medicine into the 21st Century |
| 3:00 – 3:45 pm | Break / Visit Exhibits (exhibits close 4:00 pm) |
| 3:45 pm – 4:45 pm | Plasma Dilution Therapy as a Clinical Treatment for Age Related Disorders and Aging Luis Martínez, M.D., MPH President, XanoGene Clinic, San Juan, Puerto Rico President, Regenera Global, Ponce, Puerto Rico The aging process involves and is further accelerated by the accumulation of dysfunctional and toxic proteins and components. Heterochronic parabiosis treatments have shown rejuvenating effects in animal studies. More recently, plasma dilution studies have shown similar and even better results for some age-related parameters. This lecture will cover the research as well as the clinical aspects for implementing therapeutic plasma exchange as a clinical intervention to address aging and age-related disorders. Regulatory aspects of offering such a therapy will also be discussed. |
| 4:45 pm – 5:30 pm | Managing Elevated PSA on Testosterone Therapy Brian Gerber, M.D. Attending Urologist & Chief of Surgery, St. Joseph Hospital, Elgin, IL Urology Care Center / Optimal Aging Institute When treating male patients with testosterone, the PSA can often rise either from prostate cancer or other reasons. Learn how to prevent false rises in PSA and also how to manage false elevated PSA levels in men without prostate cancer on testosterone. This lecture will help you evaluate these patients with falsely elevated PSA levels and hopefully prevent you from sending them to the Urologist for an unnecessary negative prostate biopsy. |
Sunday, April 10th
General Session Curriculum
Time |
Presentation |
|---|---|
| 8:00 – 9:00 am | The Origins of Regenerative Medicine: Stem Cells, Epigenetics and Aging Ian A. White, MS., Ph.D. Founder, President and Chief Scientific Officer, Neobiosis Regenerative medicine is the fastest growing and most dynamic field to evolve out of the contemporary allopathic method of medicine. The current trajectory of experimental and informational growth is unprecedented in our history. One might even think of this evolutionary leap in terms of Epochs. We are currently at the beginning of the third epoch of medical evolution and regenerative medicine is the driving influence guiding our advancements. But what is regenerative medicine? Using a foundation in evolutionary biology to understand the mechanisms of aging provides unprecedented opportunities for understanding the biology of tissue homeostasis and repair and how we can potentially uncouple chronological aging from biological aging to promote youthful healing in an aging patient population. |
| 9:00 – 10:00 am | Progesterone After Hysterectomy, Yeah or Nay? Testosterone in Women, Yeah or Nay? William Clearfield, D.O. Medical Director, Clearfield Family Medicine, Reno, NV Executive Director, American Osteopathic Society of Rheumatic Diseases Progesterone’s primary function in the reproductive tract is to protect the uterus from endometrial proliferation. “Conventional wisdom” and a source of controversy in hormone replacement therapy contend that women having undergone a hysterectomy no longer need progesterone. Anti-aging specialists need to know that progesterone has profound global effects due to receptors in the kidney, cardiovascular, respiratory,GI, central nervous, and bone remodeling systems. The earliest signs of progesterone deficiency occur when women enter the perimenopausal years. Progesterone is the first hormone to devolve, resulting in agitation, irritability, insomnia, poor libido, headaches, and short temperedness. The North American Menopause Society and the Endocrine Society recommend antidepressants, antihypertensive agents, and synthetic progesterone for symptom relief. Their literature confuses progestogens, synthetic progesterone, a proven carcinogen, with plant-based natural progesterone. Women have progesterone, not fluoxetine deficiencies! This lecture explores the pros and cons of progesterone therapy post-hysterectomy. We provide the learner with fifty-four (54) peer-reviewed references answering the question, Yeah or Nay? Progesterone after Hysterectomy. It provides a template to send to insurance companies and fellow physicians who cling to the outdated notion that one does not need progesterone if one does not have a uterus. |
| 10:00 – 10:15 am | Break |
| 10:15 – 11:15 am | Naltrexone Therapy in Age Management Medicine: Biological Mechanisms and Principles of Use Luis Martínez, M.D., MPH President, XanoGene Clinic, San Juan, Puerto Rico President, Regenera Global, Ponce, Puerto Rico Naltrexone is a competitive antagonist of the opioid receptors which has been used for decades in the management of substance abuse disorders. Interestingly, opioid receptors can affect multiple biological aspects including immune function and inflammation. This lecture will review the history and use of naltrexone and the biological mechanisms related the opioid receptors. Immune modulation and anti-inflammatory effects of transient receptor blockade will be discussed. The effects of the different Naltrexone dosing regimens and their biological effects will be reviewed. Finally, opioid receptor modulation and its implications will be presented as a strategy to incorporate in Age Management Medicine. |
| 11:15 am – 12:15 pm | Subcutaneous Naltrexone Therapy (SNT) For the Management of Addictions and for Weight Loss Luis Martínez, M.D., MPH President, XanoGene Clinic, San Juan, Puerto Rico President, Regenera Global, Ponce, Puerto Rico Naltrexone is FDA approved either as a stand-alone therapy or as combination therapy for the management of addictions and weight loss. One of the challenges with naltrexone therapies as it relates to these conditions is compliance. Subcutaneous Naltrexone Therapy (SNT) is an option for many patients who are candidates for therapy. This lecture will review the history of naltrexone implants and the evidence for their use. We will also detail how the actual procedure is performed and dosing will be discussed. Attendees will learn the fundamentals of incorporating Subcutaneous Naltrexone Therapy in their practices. |
| 12:15 – 1:15 pm | Protocols and Case Discussion Using Subcutaneous Naltrexone Therapy Luis Martínez, M.D., MPH President, XanoGene Clinic, San Juan, Puerto Rico President, Regenera Global, Ponce, Puerto Rico When performing Subcutaneous Naltrexone Therapy, it is important to understand dosing, possible side effects and proper follow up. This lecture will present the protocols for SNT and an interactive case discussion will ensue. Clinical pearls and pitfalls will be reviewed. Attendees will learn how proper management and integrative approaches are crucial for subcutaneous naltrexone therapy to be successful. This lecture is Non-CME. |